Free Trial

Aspira Women's Health Q1 2023 Earnings Report

Aspira Women's Health logo
$0.10 -0.01 (-8.91%)
As of 04:00 PM Eastern

Aspira Women's Health EPS Results

Actual EPS
-$10.94
Consensus EPS
-$0.75
Beat/Miss
Missed by -$10.19
One Year Ago EPS
N/A

Aspira Women's Health Revenue Results

Actual Revenue
$2.32 million
Expected Revenue
$2.30 million
Beat/Miss
Beat by +$20.00 thousand
YoY Revenue Growth
N/A

Aspira Women's Health Announcement Details

Quarter
Q1 2023
Time
N/A

Conference Call Resources

Remove Ads

Aspira Women's Health Earnings Headlines

Aspira Women’s Health receives $1.5M milestone payment from ARPA-H
“Fed Proof” Your Bank Account with THESE 4 Simple Steps
Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.
See More Aspira Women's Health Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Aspira Women's Health? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Aspira Women's Health and other key companies, straight to your email.

About Aspira Women's Health

Aspira Women's Health (NASDAQ:AWH), Inc. engages in the provision of bio-analytic and diagnostic services. Its product, OVA1, is a serum test for identifying women of having malignant ovarian tumor. Its bio-analytical solutions helps physicians diagnose, treat, and improve gynecologic health outcomes for women. The company was founded on December 9, 1993 and is headquartered in Austin, TX.

View Aspira Women's Health Profile

More Earnings Resources from MarketBeat